Oxford Genetics

Synthetic biology company, Oxford Genetics, has secured a major supply and licensing contract, worth millions, with a global ecommerce provider of reagents and tools to the research and clinical community. Read more


Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. Read more


UK-based synthetic biology company, Oxford Genetics, has established a new agreement with clinical-stage gene therapy company, MeiraGTx, for the development of novel adeno-associated virus (AAV) vectors. Read more


Oxford Genetics and Twist Bioscience have signed a new licensing agreement for the SnapFast technology platform. Read more